| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.5M | +0.8% |
| Cost of Revenue | $4.3M | -2.7% |
| Gross Profit | $5.2M | +4.0% |
| R&D Expense | $628K | +43.4% |
| SG&A Expense | $3.4M | -21.0% |
| Operating Income | $112K | +115.5% |
| Pre-tax Income | $1.4M | +357.5% |
| Income Tax | $6K | +100.7% |
| Net Income | $1.4M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $831K | -26.0% |
| Accounts Receivable | $2.3M | -10.0% |
| Inventory | $80K | +175.9% |
| Current Assets | $10.9M | -6.6% |
| Total Assets | $20.8M | +19.7% |
| Current Liabilities | $4.9M | -27.9% |
| Long-term Debt | $2.7M | — |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $137K | -91.6% |
| Capital Expenditures | $600K | -50.0% |
| Investing Cash Flow | -$987K | +50.9% |
| Financing Cash Flow | $500K | +140.4% |
| Free Cash Flow | -$463K | -206.4% |
| +339.8% |
| EPS (Basic) | $0.02 | +340.7% |
| EPS (Diluted) | $0.02 | +337.0% |
| Total Liabilities |
| $12.5M |
| +18.0% |
| Stockholders' Equity | $8.3M | +22.5% |